2021 has seen a radical disruption of the winners list among ASX dairy stocks.

Winners in recent years and months such as A2 Milk (ASX:A2M) and even Maggie Beer (ASX:MBH) have lost ground but other stocks have taken their place at the top.

Wordpress Table Plugin


The ASX dairy winners in 2021

Four ASX dairy stocks have been consistent winners this year.

Coming out on top on a yearly basis is Bioxyne (ASX:BXN) which makes infant formula supplements – powdered and added in to make it suitable for babies’ gastrointestinal systems.

The share price gain of 42 per cent came despite a 10 per cent drop in its half yearly revenue, which the company blamed on localised COVID-19 restrictions in various ASEAN markets.

However it is hoping to complete the first commercial production run of its new colostrum product in this quarter.

The biggest winner in the last month is Clover Corp (ASX:CLV) which has gained over 60 per cent.

This company too makes supplements for infant formula – and is one of the few to be focused on Europe which is a strong market because of laws governing the content of infant formulas.

Although Clover too saw a decrease in revenues of 22 per cent and net profit by 46 per cent, it claims demand has remained solid in export markets – only Australia saw reduced demand.

Sitting on a 30 per cent gain in 2021 is diversified microcap JatCorp (ASX:JAT).

It grew in earlier months with news it made a gross profit of $5.45 million for the half year and expected vaccinations and border reopenings would help demand return.

In the last month it has kept growing with news China approved its cosmetic products.

Rounding out the list of ASX dairy winners in 2021 is diversified food company Beston (ASX:BFC).

While the company parted ways with its Mt Gambier dairy farms last year, it still owns dairy factories and is currently working on a lactoferrin plant. It recently told shareholders its newly installed equipment delivered lactoferrin with purity over 95 per cent and it hopes for its first sales this quarter.

The company anticipates revenues for FY21 between $130-$145 million which would represent an increase of approximately 33 per cent on FY20.